Key facts
- It has raised $4.2M; the latest was Later Stage VC ($2.9M) in Dec 2025.
- Notable investors include Fireball Capital, Founder 2 Funder, Innovus Technology Transfer, LaunchLab, Stellenbosch University — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Immobazyme
- ·The full record, as it builds
Funding rounds
No funding rounds for Immobazyme are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Immobazyme
Operator of an analytical laboratory platform intended to create high-value products capable of solving relevant industry issues. The company offers a novel enzyme immobilization technology with precision fermentation, enabling organizations to access high-value products produced by organic synthesis and environmental remediation technologies.
- Sector
- Healthcare
- HQ
- Cape Town, South Africa
- Founded
- 2019
- Employees
- 13
- Website
- immobazyme.com/
- Ownership
- Privately Held (backing)
Immobazyme doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Immobazyme shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Immobazyme in its N-PORT filings yet. We sweep new filings monthly.